SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRamsdens Hldgs Regulatory News (RFX)

Share Price Information for Ramsdens Hldgs (RFX)

Share Price is delayed by 15 minutes
Get Live Data
442.50    7.50 (1.72%)
Bid:
440.00
Ask:
445.00
Spread: 5.00 (1.136%)
Market Cap: £143.17m
RFX Live PriceLast checked at - London Stock Exchange

Intraday Ramsdens Hldgs Share Chart

Forthcoming Board Changes

23 May 2024 07:00

RNS Number : 5384P
Ramsdens Holdings PLC
23 May 2024
 

23 May 2024

Ramsdens Holdings PLC

("Ramsdens", the "Group", the "Company")

Forthcoming Board Changes

 

Ramsdens, the diversified financial services provider and retailer, announces the following Board changes as part of its succession planning.

Andrew (Andy) Meehan, who has been Non-Executive Chair of the Group since September 2014 has notified the Board of his intention to step down and will not seek re-election at the Group's next AGM, expected to be in March in 2025. 

At the same time, we are pleased to announce that Simon Herrick, currently the Group's Senior Independent Director, who joined the Board in 2017 will become Non-Executive Chair when Andy steps down next year.

The Board would like to express its appreciation to Andy for his invaluable contributions to the Company over the last decade. Andy joined Ramsdens when Peter Kenyon led a management buyout from the Smith family, backed by NorthEdge Capital LLP. He has overseen the successful transition of Ramsdens from a family owned business, to a PE backed business and now 7 years quoted on AIM. During this time on AIM, the Group has increased profit before tax from £4m to over £10m and grown the net assets of the business from £23m to £48m.

A recruitment process will now commence for a new Non-Executive Director to further widen the skills and experience of the Board.

Andy Meehan said: "It has been an extraordinary privilege to Chair this business over the last 10 years. Ramsdens has a very talented team of people and I have enjoyed assisting in the Group's development. I am very pleased that Simon will succeed me as Chair in due course and am confident that he will continue to drive this outstanding business forward."

Simon Herrick said: "Andy has chaired the business very successfully through an ever‐changing economic landscape including the unprecedented period of uncertainty caused by the Covid-19 pandemic. I am honoured and excited to have the opportunity to become Chair of Ramsdens and continue to work closely with the exceptional leadership team to create further shareholder value."

 

ENDS

Enquiries:

Ramsdens Holdings PLC Tel: +44 (0) 1642 579957

Peter Kenyon, CEO

Martin Clyburn, CFO

 

Liberum Capital Limited (Nominated Adviser) Tel: +44 (0) 20 3100 2000

Richard Lindley

Will King

 

 

Hudson Sandler (Financial PR) Tel: +44 (0) 20 7796 4133

Alex Brennan

Lucy Wollam-Coles

Emily Brooker

 

About Ramsdens

Ramsdens is a growing, diversified, financial services provider and retailer, operating in the four core business segments of foreign currency exchange, pawnbroking loans, precious metals buying and selling and retailing of second hand and new jewellery. 

 

Ramsdens does not offer unsecured high-cost short term credit.

 

Headquartered in Middlesbrough, the Group operates from 168 stores within the UK (including one franchised store) and has a growing online presence.

 

Ramsdens is fully FCA authorised for its pawnbroking and credit broking activities.

 

www.ramsdensplc.com

www.ramsdensforcash.co.uk

www.ramsdensjewellery.co.uk

www.ramsdenscurrency.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAQKBBNABKDOPB
Date   Source Headline
3rd Jun 20267:00 amRNSInterim Results - six months ended 31 March 2026
6th May 20267:00 amRNSTrading Update
7th Apr 20262:54 pmRNSDirector/PDMR Shareholding
7th Apr 202611:54 amRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSTrading Update
9th Mar 20263:38 pmRNSResult of AGM
9th Mar 20263:38 pmRNSResult of AGM
12th Feb 20261:45 pmRNSHolding(s) in Company
10th Feb 20267:00 amRNSTrading Update
23rd Jan 20267:00 amRNSNotice of AGM
14th Jan 20267:00 amRNSAnnual Results - year ended 30 September 2025
7th Jan 20267:00 amRNS-RNotice of Annual Results Investor Presentation
12th Dec 20257:00 amRNSAppointment of Nominated Adviser and Broker
24th Nov 20257:00 amRNSDirector/PDMR Shareholding
17th Nov 202510:08 amRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNS-RNotice of Investor Presentation
8th Oct 20257:00 amRNSPre-Close Trading Update
10th Sep 20252:17 pmRNSHolding(s) in Company
21st Aug 20259:35 amRNSHolding(s) in Company
19th Jun 202510:47 amRNSHolding(s) in Company
18th Jun 20257:00 amRNSDirector/PDMR Shareholding
4th Jun 20257:00 amRNSInterim Results - six months ended 31 March 2025
16th May 20257:00 amRNSNotice of Interim Results & Investor Presentation
2nd May 20257:00 amRNSDirector/PDMR Shareholding
28th Apr 20252:54 pmRNSHolding(s) in Company
24th Apr 20259:47 amRNSDirector/PDMR Shareholding
8th Apr 20257:00 amRNSTrading Update
17th Mar 20254:05 pmRNSChange of Registered Office Address
14th Mar 20253:21 pmRNSDirector/PDMR Shareholding
13th Mar 202510:58 amRNSCSOP update
3rd Mar 20254:27 pmRNSResult of AGM
3rd Mar 20257:00 amRNSAGM Business Update
29th Jan 20257:00 amRNSIssue of Equity, PDMR and Total Voting Rights
23rd Jan 202512:46 pmRNSNotice of AGM
14th Jan 20257:00 amRNSAnnual Results - year ended 30 September 2024
28th Oct 20243:55 pmRNSHolding(s) in Company
11th Oct 20244:31 pmRNSHolding(s) in Company
10th Oct 20247:00 amRNSPre-Close Trading Update and Notice of Results
8th Oct 20247:00 amRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSAppointment of Non-Executive Director
8th Aug 20247:00 amRNSDirector/PDMR Shareholding
6th Aug 20247:00 amRNSTrading Update
1st Jul 20247:00 amRNSNominated Adviser and Broker
5th Jun 202411:42 amRNSHolding(s) in Company
5th Jun 20247:00 amRNSInterim Results - six months ended 31 March 2024
24th May 202410:51 amRNSHolding(s) in Company
24th May 20247:00 amRNSNotice of Interim Results Investor Presentation
23rd May 20247:00 amRNSForthcoming Board Changes
16th May 20247:00 amRNSNotice of Interim Results
14th May 202412:59 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.